Articles From: - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX to 2014/12/12 - MinuteClinic Walk-in Medical Clinics Open in Northern Nevada


2014/12/12
Positive Results of Largest Genomic Study in DCIS Reconfirm Oncotype DX is a Strong, Independent Predictor of Local Recurrence Oral Presentation, Featured in the 2014 San Antonio Breast Cancer Symposium Press Program, to Occur on December 12 at 10:15 a.m. Central Time SAN ANTONIO , Dec.
Sign-up for 2014/12/12 - Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast Cancer investment picks
2014/12/12
Goldberg puts more emphasis on insight and operational excellence to grow retail leadership FORT LAUDERDALE, Fla.
Sign-up for 2014/12/12 - New CEO Realigns Leadership Team at Zimmerman investment picks
GoPro Inc.'s stock (GPRO) rallied 2.7% in premarket trade Friday, after analyst Paul Coster at J.P. Morgan Chase upgraded it to overweight from neutral, saying the recent sharp price decline makes it more attractive.
Sign-up for - UPDATE: GoPro's stock rallies after analyst upgrade investment picks
IRVINE, Calif., Dec.
Sign-up for - Autobytel Conducts NADA Workshops Focused on Texting Best Practices investment picks
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that interim results from an ongoing Phase II clinical trial of Puma's investigational drug PB272 (neratinib) were presented at the 2014 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, Texas.
Sign-up for - Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data at 2014 CTRC-AACR San Antonio Breast Cancer Symposium investment picks
2014/12/12
Technology will quadruple HudsonAlpha's DNA sequencing capacity to help genomic information reach thousands of patients HUNTSVILLE, Ala.
Sign-up for 2014/12/12 - HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system investment picks
2014/12/12
Citi today announced it will begin a multi-year sponsorship of Share Our Strength’s No Kid Hungry® campaign to support the non-profit organization’s mission to ensure that no child in the United States goes hungry.
Sign-up for 2014/12/12 - Citi Joins No Kid Hungry to End Childhood Hunger in the U.S. investment picks
2014/12/12
By Mitch Rothschild Better medical choices and outcomes benefit patients A tidal wave of innovation is going to affect health care.
Sign-up for 2014/12/12 - UPDATE: 5 health-care sector prescriptions for 2015 investment picks
2014/12/12
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks sank Friday, driving the Stoxx Europe 600 to its worst week in more than three years, as energy shares continued to take blows from the oil-price slide.
Sign-up for 2014/12/12 - UPDATE: European stocks, Russian ruble skid as oil prices slump investment picks
InvenSense, Inc. (NYSE: INVN), the leading provider of intelligent sensor solutions, received its fourth prestigious award at the 2014 Global Semiconductor Alliance (GSA) Awards Dinner Celebration.
Sign-up for - InvenSense® Receives Fourth Prestigious Global Semiconductor Alliance Award In Three Consecutive Years investment picks
2014/12/12
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pointed to a red open on Wall Street on Friday, as a further slump in oil prices continued to dampen the investment mood and fanned fears of an imminent stock-market correction.
Sign-up for 2014/12/12 - U.S. stocks: Futures bruised by continued oil selloff investment picks
JPMorgan Chase & Co.
Sign-up for - JPMorgan Chase Declares Preferred Stock Dividend investment picks
2014/12/12
By Angela Chen The U.S. Food and Drug Administration has approved Eli Lilly Co.'s Cyramza to treat non-small cell lung cancer, the most common type of lung cancer.
Sign-up for 2014/12/12 - FDA approves Eli Lilly's Cyramza for lung cancer investment picks
http://media.marketwire.com/attachments/201406/258111_Performancelogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164740&ProfileId=051205&sourceType=1 EXETER, NH --
Sign-up for - Performance Sports Group Announces Resolution Regarding Cascade R Lacrosse Helmet investment picks
2014/12/12
(Please see the next page for more sports items.) -Jason Notte; 415-439-6400; AskNewswires@dowjones.com Postgame highlights: Who needs a hug, huh?
Sign-up for 2014/12/12 - Top 5, bottom 5 college football bowl games -3- investment picks
Cinemark Holdings, Inc. (NYSE: CNK), one of the world’s leading motion picture exhibitors will present, for one day only, on Monday, December 15, The Hobbit Movie Marathon .
Sign-up for - Cinemark Announces The Hobbit Movie Marathon investment picks
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014.
Sign-up for - Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Oil's plunge has blown a billion-dollar hole in Elon Musk's pocket -- and that's just since late November.
Sign-up for - This is how much Elon Musk has lost because of oil's plunge investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, today announced that due to the resignation of one of the submitting banks, ICE Benchmark Administration (IBA) will suspend the ISDAFIX Swiss franc (CHF) from its portfolio of benchmarks.
Sign-up for - IBA to Suspend ISDAFIX Swiss Franc (CHF) Rate investment picks
Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) ( http://www.rgrdlaw.com/cases/jumei/ ) today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Jumei International Holding Limited (“Jumei”) (NYSE:JMEI) American Depositary Shares (“ADSs”) between May 16, 2014, the date of Jumei’s initial public offering (“IPO”), and November 19, 2014.
Sign-up for - Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Jumei International Holding Limited investment picks
Highlights 3D printing's integral role in the design to manufacturing digital thread Marks museum's re-opening and new, interactive visitor experience Company to lead workshops at Kids and Family Day this weekend ROCK HILL, S.C., Dec.
Sign-up for - Photo Release -- 3D Systems' Digital Craftsmanship on Display at Cooper Hewitt, Smithsonian Design Museum investment picks
THE WOODLANDS, Texas , Dec.
Sign-up for - CB&I Announces Placement of CA05 Module investment picks
2014/12/12
First Locations Inside Select CVS/pharmacy stores in Reno and Sparks WOONSOCKET, R.I. , Dec.
Sign-up for 2014/12/12 - MinuteClinic Walk-in Medical Clinics Open in Northern Nevada investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX to 2014/12/12 - MinuteClinic Walk-in Medical Clinics Open in Northern Nevada
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent